Selection of patients for cardiac resynchronisation therapy (CRT) in an unselected heart failure population
Insights
Many patients with chronic heart failure (CHF) qualify for cardiac resynchronisation therapy (CRT) based on current QRS width and ejection fraction criteria. Expanding criteria could identify more suitable candidates for CRT.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Chronic heart failure (CHF) patients often exhibit myocardial conduction delay.
- Cardiac resynchronisation therapy (CRT) is increasingly used for CHF.
- Current CRT selection relies on left ventricular ejection fraction (LVEF) ≤35% and QRS widening, with or without left bundle branch block (LBBB).
Purpose of the Study:
- To evaluate the proportion of CHF patients in a standard cardiology practice suitable for CRT.
- To assess the impact of current and potential future criteria on CRT candidacy.
Main Methods:
- Retrospective analysis of 861 CHF patients from January 2000 to December 2004.
- Evaluation of LVEF, QRS width, and LBBB morphology.
- Inclusion of patients with LVEF ≤35% and QRS width >120 msec or >140 msec.
- Consideration of patients with LBBB and univentricular pacing devices.
Main Results:
- 309 out of 861 CHF patients had LVEF ≤35%.
- Among these, 123 had QRS width >120 msec and 81 had QRS width >140 msec.
- 89 patients presented with LBBB morphology.
Conclusions:
- A significant number of CHF patients meet current CRT eligibility criteria.
- Potential exists to increase CRT candidate numbers by considering intraventricular conduction delay with less pronounced QRS widening, assessed via echocardiography.
Background:
In patients with chronic heart failure (CHF), the presence of conduction delay across the myocardium is a well-known feature. During recent years an increasing number of CHF patients have been treated with cardiac resynchronisation therapy (CRT). So far in many protocols patients have been selected using the criteria of left ventricular ejection fraction (LVEF) ≤35% concomitant with signs of widening of the QRS on the surface electrocardiogram, either with or without left bundle branch block (LBBB) morphology.
Methods:
In this article we discuss which of the patients admitted with CHF to a regular cardiology practice could be candidates for this therapy. Data were obtained from January 2000 to December 2004 on a total of 861 CHF patients, of whom 309 had an LVEF ≤35%. Of these patients, 123 patients showed a QRS width >120 msec, while 81 patient had a QRS width >140 msec. In total, 89 patients had an LBBB morphology on the electrocardiogram, while 21 patients had univentricular pacing devices in situ. In those patients with an LVEF >35%, QRS width was 108±27msec.
Conclusion:
A substantial number of patients presenting with CHF in a regular cardiology practice are suitable candidates for CRT therapy according to currently used criteria of QRS width and LVEF. This number could be increased even more if recent information concerning intraventricular conduction delay in CHF patients with less widening of the QRS complex were to be applied, as judged by echocardiographic techniques.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System


